Company Profile

OBI Pharma, Inc. 

Stock Code

4174.TWO

Market

Taipei Exchange

Industry Type

Biotech & Medical Care

Principal Activities

New drugs research

Date of Establishment

2022/04/29

Date of Listing

2015/03/23

Capital

NT$ 2,294,393,740

Chairman

Kung-Yee Liang

Number of Employees

140

Stock Transfer Agent

MasterLink Securities Corporation

Auditors

PricewaterhouseCoopers Taiwan

Principal Office

6F., No.508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City, Taiwan

Tel

(02) 2655-8799

Fax

(02) 2655-8798、(02) 2786-6590

E-mail

info@obipharma.com

Website

www.obipharma.com/